-
Mashup Score: 0
SKB264 led to durable responses and a manageable safety profile in patients with gastric or gastroesophageal junction cancers, an expert said.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0
SKB264 led to durable responses and a manageable safety profile in patients with gastric or gastroesophageal junction cancers, an expert said.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
The SKB264 antibody-drug conjugate demonstrated durable responses and better disease control in pretreated patients with #GastricCancers and gastroesophageal #cancer, according to Dr. Jordi Rodon of @MDAndersonNews. Read more about it: https://t.co/kJ8pgxMezu